Orient Europharma Co Ltd (4120) — Cash Flow Reinvestment Rate
Orient Europharma Co Ltd (4120) has a Cash Flow Reinvestment Rate of 44.08x as of June 2025, reinvesting NT$1.47 Billion (capex NT$89.03 Million plus investments NT$1.38 Billion) from operating cash flow of NT$33.25 Million. See Orient Europharma Co Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Orient Europharma Co Ltd Cash Flow Reinvestment Rate (2015–2023)
Historical reinvestment intensity for Orient Europharma Co Ltd across 8 annual periods. For the full cash flow conversion analysis, see Orient Europharma Co Ltd (4120) cash conversion ratio.
Annual Cash Flow Reinvestment Rate for Orient Europharma Co Ltd (2015–2023)
Year-by-year capital reinvestment analysis for Orient Europharma Co Ltd. See Orient Europharma Co Ltd (4120) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 5.44x | NT$351.83 Million | NT$64.67 Million | NT$100.70 Million | ▼ -75.1% |
| 2021 | 21.89x | NT$1.70 Billion | NT$77.65 Million | NT$1.56 Billion | ▲ +3647.9% |
| 2020 | 0.58x | NT$355.35 Million | NT$608.55 Million | NT$232.78 Million | ▲ +4.4% |
| 2019 | 0.56x | NT$127.14 Million | NT$227.37 Million | NT$124.98 Million | ▼ -36.0% |
| 2018 | 0.87x | NT$202.21 Million | NT$231.31 Million | NT$201.61 Million | ▲ +9.7% |
| 2017 | 0.80x | NT$478.86 Million | NT$601.08 Million | NT$367.66 Million | ▼ -85.4% |
| 2016 | 5.47x | NT$608.30 Million | NT$111.24 Million | NT$224.81 Million | ▲ +912.9% |
| 2015 | 0.54x | NT$347.66 Million | NT$643.97 Million | NT$229.54 Million | — |